Synthes Confirms J&J Merger Talks

Xconomy New York — 

Johnson & Johnson (NYSE: JNJ) is in discussions with Swiss medical device maker Synthes about a potential merger, according to a statement today from Synthes. Rumors emerged on Friday that New Brunswick, NJ-based J&J was considering picking up Synthes for as much as $20 billion. Synthes makes a variety of devices used in spinal surgery, hand and wrist procedures, and other surgical settings. JNJ’s stock was up about a half a percent in morning trading, to $60.89.